A Small-Molecule Triptolide Suppresses Angiogenesis and Invasion of Human Anaplastic Thyroid Carcinoma Cells via Down-Regulation of the Nuclear Factor-κB Pathway
Authors:
- Yanqiu OuYOYanqiu Ou
- Yan LiYLYan Li
- Ru XiaoRXRu Xiao
- Minfeng ShuMSMinfeng Shu
- Yuehan ZhouYZYuehan Zhou
- Jun XieJXJun Xie
- Songmin HeSHSongmin He
- Pengxin QiuPQPengxin Qiu
- Guangmei YanGYGuangmei Yan
- 1 April 2009
- journal article
- research article
- Published by Elsevier in Molecular Pharmacology
- Vol. 75 (4) , 812-819
Abstract
Anaplastic thyroid carcinoma (ATC) is among the most aggressive malignancies known and is characterized with rapid growth, early invasion, and complete refractoriness to current therapies. Here we report that triptolide, a small molecule from a Chinese herb, could potently inhibit proliferation in vitro, angiogenesis in vivo, and invasion in a Matrigel model in human ATC cell line TA-K cells at nanomolar concentrations. We further elucidate that triptolide inhibits the nuclear factor-κB (NF-κB) transcriptional activity via blocking the association of p65 subunit with CREB-binding protein (CBP)/p300 in the early stage and via decreasing the protein level of p65 in the late stage. Expression of the NF-κB targeting genes cyclin D1, vascular endothelial growth factor, and urokinase-type plasminogen activator is significantly reduced by triptolide in both TA-K and 8505C human ATC cell lines, which are well known to be critical for proliferation, angiogenesis, and invasion in solid tumors. Our findings suggest that triptolide may function as a small molecule inhibitor of tumor angiogenesis and invasion and may provide novel mechanistic insights into the potential therapy for human ATC.Keywords
This publication has 35 references indexed in Scilit:
- Apigenin inhibits tumor angiogenesis through decreasing HIF-1 and VEGF expressionCarcinogenesis, 2006
- Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapyBiochemical and Biophysical Research Communications, 2005
- Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and AngiogenesisJournal of Clinical Oncology, 2005
- Nuclear factor-κBCancer Cell, 2004
- The biology of VEGF and its receptorsNature Medicine, 2003
- Triptolide and Chemotherapy Cooperate in Tumor Cell ApoptosisJournal of Biological Chemistry, 2001
- Triptolide, A Novel Immunosuppressive and Anti-Inflammatory Agent Purified from a Chinese Herb Tripterygium Wilfordii Hook FLeukemia & Lymphoma, 2001
- Angiogenesis in cancer and other diseasesNature, 2000
- Clinical applications of angiogenic growth factors and their inhibitorsNature Medicine, 1999
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996